BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vus K, Tarabara U, Danylenko I, Pirko Y, Krupodorova T, Yemets A, Blume Y, Turchenko V, Klymchuk D, Smertenko P, Zhytniakivska O, Trusova V, Petrushenko S, Bogatyrenko S, Gorbenko G. Silver nanoparticles as inhibitors of insulin amyloid formation: A fluorescence study. Journal of Molecular Liquids 2021;342:117508. [DOI: 10.1016/j.molliq.2021.117508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rosetti B, Marchesan S. Peptide Inhibitors of Insulin Fibrillation: Current and Future Challenges. Int J Mol Sci 2023;24. [PMID: 36674821 DOI: 10.3390/ijms24021306] [Reference Citation Analysis]
2 Lu SS, Lai Y, Hsiao L, Huang H, Tsai Y, Chen Y, Wang SS, Yeh Y, Tsai S. Effects of Amino Acid-Functionalized Silver Nanoparticles on Lysozyme Amyloid Fibrillogenesis. Colloids and Surfaces B: Biointerfaces 2023. [DOI: 10.1016/j.colsurfb.2023.113144] [Reference Citation Analysis]
3 Yamamoto N, Inoue R, Makino Y, Sekiguchi H, Shibayama N, Naito A, Sugiyama M, Chatani E. Tracking the Structural Development of Amyloid Precursors in the Insulin B Chain and the Inhibition Effect by Fibrinogen. J Phys Chem B 2022;126:10797-812. [PMID: 36534755 DOI: 10.1021/acs.jpcb.2c05136] [Reference Citation Analysis]
4 Qafary M, Rashno F, Khajeh K, Khaledi M, Moosavi-movahedi AA. Insulin fibrillation: Strategies for inhibition. Progress in Biophysics and Molecular Biology 2022. [DOI: 10.1016/j.pbiomolbio.2022.09.001] [Reference Citation Analysis]
5 Dzhagan V, Pirko Y, Buziashvili A, Plokhovska S, Borova M, Yemets A, Mazur N, Kapush O, Yukhymchuk V. Контрольована агрегація плазмонних наночастинок для підвищення ефективності SERS-підкладок. Ukr J Phys 2022;67:80. [DOI: 10.15407/ujpe67.1.80] [Reference Citation Analysis]